Detalhe da pesquisa
1.
Histone Modifications and Their Targeting in Lymphoid Malignancies.
Int J Mol Sci
; 23(1)2021 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008680
2.
Different Gene Sets Are Associated With Azacitidine Response In Vitro Versus in Myelodysplastic Syndrome Patients.
Hemasphere
; 6(11): e792, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310757
3.
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines.
Cell Rep
; 39(12): 110988, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732123
4.
Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy.
Cancers (Basel)
; 13(7)2021 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917538
5.
Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18.
Sci Rep
; 11(1): 21145, 2021 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707142
6.
Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis.
Nat Commun
; 12(1): 6060, 2021 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663789
7.
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.
Clin Epigenetics
; 11(1): 121, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439048